Time to start addressing (and not just describing) the social determinants of diabetes: results from the NEXT-D 2.0 network

Affiliations

¹ Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA yuo0@cdc.gov.
² Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
³ Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, California, USA.
⁴ Tulane University School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
⁵ Division of General Internal Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
⁶ Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
⁷ Patient-Centered Outcomes Research Institute, Washington, DC, USA.
⁸ Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
⁹ Department of Global Heatlh, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Editorial

Karen R Siegel et al. BMJ Open Diabetes Res Care. 2021 Dec.

. 2021 Dec;9(Suppl 1):e002524.

doi: 10.1136/bmjdrc-2021-002524.

¹ Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA yuo0@cdc.gov.
² Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
³ Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, California, USA.
⁴ Tulane University School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
⁵ Division of General Internal Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
⁶ Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
⁷ Patient-Centered Outcomes Research Institute, Washington, DC, USA.
⁸ Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
⁹ Department of Global Heatlh, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

No abstract available

Keywords: diabetes mellitus; type 2.

Conflict of interest statement

Competing interests: None declared.

1. Ali MK, McKeever Bullard K, Imperatore G, et al. . Reach and use of diabetes prevention services in the United States, 2016-2017. JAMA Netw Open 2019;2:e193160–e60. 10.1001/jamanetworkopen.2019.3160 - DOI - PMC - PubMed
1. Canedo JR, Miller ST, Schlundt D, et al. . Racial/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status. J Racial Ethn Health Disparities 2018;5:7–14. 10.1007/s40615-016-0335-8 - DOI - PMC - PubMed
1. Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications. JAMA 2019;321:1867–8. 10.1001/jama.2019.3471 - DOI - PubMed
1. Saydah S, Lochner K. Socioeconomic status and risk of diabetes-related mortality in the U.S. Public Health Rep 2010;125:377–88. 10.1177/003335491012500306 - DOI - PMC - PubMed
1. Hill-Briggs F, Adler NE, Berkowitz SA, et al. . Social determinants of health and diabetes: a scientific review. Diabetes Care 2020:279. 10.2337/dci20-0053 - DOI - PMC - PubMed